Cargando…
Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials
BACKGROUNDS: Diabetic nephropathy (DN) is one of the most important clinical complications of diabetes mellitus (DM) and is the most common cause of end-stage renal disease. Currently, there is no highly effective medicine that can prevent, halt, or reverse the progressive course of DN. Initial clin...
Autores principales: | Guo, Hua-Bin, Peng, Jia-Qing, Xuan Wang, Zhang, Ke-Kai, Zhong, Guang-Zhi, Chen, Wei-Hong, Shi, Gui-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425142/ https://www.ncbi.nlm.nih.gov/pubmed/34493223 http://dx.doi.org/10.1186/s12882-021-02487-8 |
Ejemplares similares
-
Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis
por: Wu, Xue, et al.
Publicado: (2020) -
Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
por: Hong, Yan, et al.
Publicado: (2016) -
Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy: A protocol for meta-analysis
por: Ma, Chang-e, et al.
Publicado: (2021) -
The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021) -
Effects of tripterygium glycosides on restenosis following endovascular treatment
por: HAN, BING, et al.
Publicado: (2016)